Nefazodone, psychotherapy, and their combination for chronic depression [1] (multiple letters)

New England Journal of Medicine

Volumn 343, Issue 14, 2000, Pages 1041-1043

  Rubin, R T ^a   Umanoff, D F ^a   Veijola, J M ^a   Duncan, B L ^a   Miller, S D ^a   Keller, M B ^a   Klein, D N ^a   Thase, M E ^a  

^a ALLEGHENY GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEFAZODONE; ANTIDEPRESSANT AGENT; PLACEBO; TRIAZOLE DERIVATIVE;

DEPRESSION; DRUG EFFICACY; LETTER; OUTCOMES RESEARCH; PRIORITY JOURNAL; PSYCHOTHERAPY; SCORING SYSTEM; STATISTICAL ANALYSIS; TREATMENT OUTCOME; CHRONIC DISEASE; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; HUMAN; METHODOLOGY; MULTIMODALITY CANCER THERAPY; NOTE;

ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CHRONIC DISEASE; COMBINED MODALITY THERAPY; CONTROLLED CLINICAL TRIALS; DEPRESSIVE DISORDER; HUMANS; PLACEBOS; PSYCHOTHERAPY; RESEARCH DESIGN; TRIAZOLES;

EID: 0034610028     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200010053431410     Document Type: Letter

References (0)